TLX

Is Telix (ASX:TLX) Quietly Assembling a Connected Oncology Platform That Reshapes Its Moat?

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

Telix Pharmaceuticals: PSMA Radiopharmaceutical Player Is Revving Up

Telix Pharmaceuticals' IPAX-2 Study Of TLX101-Tx Completes Patient Enrolment; Maximum Dose Reached With No Dose-limiting Toxicities Observed; TLX101-Tx Is Also The Subject Of A Pivotal Trial, IPAX BrIGHT, Which Is Actively Dosing Patients With Recurrent Glioblastoma

Why Is Regeneron Stock Sinking Monday?

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches